Français
Search this site:
Symbol
Last
Change
IPN.PA
20.35 €
(-1.21 % )
powered by Euronext©
The Group
Profile & Key figures
Message from the Chairman
Group history
R & D
R & D Homepage
Neurology
Endocrinology
Oncology
Primary care
Medicines
Governance
Board of directors
Executive committee
Board committees
Compensation of corporate officers
Business Development & Alliance Management
Ipsen worldwide
Targeted diseases
Neurology
Endocrinology
Oncology
Hematology
Primary care
Commitments
Vision, mission and values
Environment, health and safety
Ethics and compliance
Support to Patient Organizations
Solidarity
Fondation IPSEN
La Fondation Ipsen at a glance
Colloques, prizes, publications
Neurosciences
Alzheimer’s disease
Endocrinology
Cancer science
Longevity
Vascular
Partnerships
Salk Institute - Nature
Cell Press - Massachusetts General Hospital
Nature Publishing Group
Press releases
18 May 2012
- Lund (Sweden) and Paris (France)
Active Biotech and Ipsen to present Tasquinimod Phase II Overall Survival data at the 2012 ASCO Annual Meeting
Download
11 May 2012
- Paris (France)
The 10th Endocrine Regulation Prize of the Fondation Ipsen is awarded to Paolo Sassone-Corsi
Download
3 May 2012
- Paris (France)
Ipsen’s first quarter 2012 sales
Download
News
02 May 2012
Publication of Ipsen 2011 Registration document
Download
Lire la suite
Go to
Print
Press room
Investor relations
Careers
YOUR SERVICES
Publications
Email alert
Follow Ipsen on